Skip to main content

Table 3 Levels of Apolipoproteins and HMGCR in different groups \( \left(\overline{x} \pm \mathrm{s}\right) \)

From: Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway

Group

N

ApoA-I(pg/ml)

Apo-B(pg/ml)

LP(a) (pg/ml)

HMGCR(ng/ml)

Sham

12

488.00 ± 3.04*

24.00 ± 13.02**

100.00 ± 12.35

2.86 ± 1.07**

Model

12

460.00 ± 9.33

58.00 ± 8.37

130.00 ± 42.43

5.67 ± 1.53

Danqi pill

12

482.86 ± 6.96*

16.67 ± 14.14**

102.00 ± 6.32

2.00 ± 1.69**

Positive Drug

12

471.11 ± 16.16

31.25 ± 17.27**

145.56 ± 87.91

1.13 ± 0.30*

  1. *P < 0.05, **P < 0.01,Levels in the model group were used as reference to calculate P values.
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us